Search Result "tivantinib"
Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1331-1340
Author(s): Leticia G. Leon,Maria Gemelli,Rocco Sciarrillo,Amir Avan,Niccola Funel,Elisa Giovannetti
Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile
Journal: Current Drug Safety
Volume: 10 Issue: 3 Year: 2015 Page: 202-207
Author(s): Antonio Facciorusso,Matteo Antonino,Valentina Del Prete,Annabianca Amoruso,Viviana Neve,Michele Barone
Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 39 Year: 2018 Page: 4619-4625
Author(s): Sadaf Ghanaatgar-Kasbi,Shadi Khorrami,Amir Avan,Seyed A. Aledavoud,Gordon A. Ferns
The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 37 Year: 2012 Page: 6155-6168
Author(s): Assunta Sgambato,Francesca Casaluce,Paolo Maione,Antonio Rossi,Emanuela Rossi,Alba Napolitano,Giovanni Palazzolo,Maria Anna Bareschino,Clorinda Schettino,Paola Claudia Sacco,Fortunato Ciardiello,Cesare Gridelli
Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials
Journal: Clinical Cancer Drugs
Volume: 3 Issue: 2 Year: 2016 Page: 87-99
Author(s): Yin Yin,He Wang,Mingjie Lu,Wei Zhu
The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo
Precision Medicine in Improving Treatment Outcomes in Hepatocellular Carcinoma: Clinical Outcomes and Advancements
Ebook: Precision Medicine and Human Health
Volume: 1 Year: 2024
Author(s): Mohammad Afsar Khan,Hifzur R. Siddique
Doi: 10.2174/9789815223583124010007
MET and ALK as Targets for the Treatment of NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1263-1272
Author(s): Shigehiro Yagishita,Akinobu Hamada
The Role of Tyrosine Kinase Inhibitors in Reduction of Mortality fromNon-small Cell Lung Cancer: A Meta-analysis
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 5 Year: 2023 Page: 928-937
Author(s):